New Players in Life Science Innovation, The: Best Practices in R&D from Around the World, The

Product Author Bios

Tomasz Mroczkowski (Washington, DC) is full professor of International Business at American University's Kogod School of Business. He teaches international business and management in emerging economies in its MBA program, and teaches in the special masters program in biotechnology management at the ESCP-EAP business school in Paris, France. Mroczkowski researches innovation and business development in emerging economies, international outsourcing, and R&D globalization in the life science/biotech industries. He has been featured on NBC Nightly News, was interviewed by Tokyo Shinbun and Shinichi Shinbun, and contributed to The Asian Wall Street Journal and Japan Times.

The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.

Table of Contents

Acknowledgments     viii

About the Author     ix

Chapter 1 Power Shifts in Global R&D and Innovation: What They Mean for Firms in Life Science Businesses     1

Chapter 2 The Race for the Best National Innovation System: Who Has the Most Effective Strategy     37

Chapter 3 A Reshuffling of Markets and Growth Opportunities     73

Chapter 4 Improving R&D Productivity: Contract Research and Discovery Collaborations with the New Players as Solutions     109

Chapter 5 Globalization of Clinical Trials: It Is Not Just About Slashing Costs     151

Chapter 6 Accelerating Innovation: Bioparks, Technology Zones, and Emerging Clusters     193

Chapter 7 Company Strategies of Global R&D Collaborations: From West Meets West to West Meets East     229

Chapter 8 The Future: The Expanding Universe of Global Innovation     269

Endnotes     303

Index     331